US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Merck
Browsing Tag
Merck
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…
Merck and 10x Genomics launch new option for CRISPR research
The companies will work together as part of 10x Genomics’ 10x Compatible Partnership Program, a global ecosystem of technologies…
Merck’s Liquid Crystal Windows Business and Guardian Glass announce strategic partnership
With this partnership, Merck aims to expand the customer base of its Liquid Crystal Windows business by leveraging additional…
Merck to unveil its latest innovation during Live Virtual Launch on June 18
Redesigns its Benchtop Pure Water Solution – the Milli-Q® IX Pure Water Purification System
FDA approves Merck’s antibiotic drug to treat hospital-acquired bacterial pneumonia
The FDA is granting the approval to Merck for the drug, Recarbrio
Merck registers an increase of 16.7 per cent in net sales
The COVID-19 crisis, which has meanwhile become a pandemic, only had a moderate impact in the first quarter of 2020, the company…
Merck Granted US Patents for Foundational CRISPR-Cas9 Technology
CRISPR technology is a core competency for Merck, which has 16 years’ experience with genome editing, spanning discovery to…
Merck boosts commercial viral vector and gene therapy manufacturing capacity
The new, € 100 million commercial facility is expected to open next year
Merck awarded second US patent for CRISPR Gene-Editing Technology
CRISPR-chrom technology improves access to genome for more efficient editing